These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35783478)

  • 1. Synergistic antioxidant and anti-inflammatory action of N-acetylcysteine in portal hypertensive gastropathy in rats.
    Licks F; Minuzzo Hartmann R; Schemitt E; Raskopf Colares J; Marques C; Fillmann H; Possa Marroni N
    Hepatol Forum; 2022 May; 3(2):51-56. PubMed ID: 35783478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.
    Licks F; Hartmann RM; Marques C; Schemitt E; Colares JR; Soares Mdo C; Reys J; Fisher C; da Silva J; Marroni NP
    World J Gastroenterol; 2015 Nov; 21(43):12351-60. PubMed ID: 26604642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effect of N-acetylcysteine on prehepatic portal hypertensive gastropathy in rats.
    Licks F; Marques C; Zetler C; Martins MI; Marroni CA; Marroni NP
    Ann Hepatol; 2014; 13(3):370-7. PubMed ID: 24756013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy.
    Marques C; Licks F; Zattoni I; Borges B; de Souza LE; Marroni CA; Marroni NP
    World J Gastroenterol; 2013 Jul; 19(28):4464-74. PubMed ID: 23901221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of estrogen in portal hypertension gastropathy: an experimental model.
    Morgan-Martins MI; Jacques SI; Hartmann RM; Marques CM; Marroni CA; Marroni NP
    Arq Gastroenterol; 2011; 48(3):211-6. PubMed ID: 21952708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy.
    Marques C; Mauriz JL; Simonetto D; Marroni CA; Tuñon MJ; González-Gallego J; Marrón NP
    Ann Hepatol; 2011; 10(4):531-9. PubMed ID: 21911895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine prevents oxidative stress in a model of portal hypertension.
    Zabot GP; Carvalhal GF; Marroni NP; Licks F; Hartmann RM; da Silva VD; Fillmann HS
    World J Gastroenterol; 2017 Jul; 23(25):4529-4537. PubMed ID: 28740341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
    Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M
    J Hepatol; 2009 Nov; 51(5):865-73. PubMed ID: 19726100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats.
    Moreira AJ; Fraga C; Alonso M; Collado PS; Zetller C; Marroni C; Marroni N; González-Gallego J
    Biochem Pharmacol; 2004 Nov; 68(10):1939-46. PubMed ID: 15476665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial flow becomes the primary supply of sinusoids following partial portal vein ligation in rats.
    Yokoyama Y; Wawrzyniak A; Sarmadi AM; Baveja R; Gruber HE; Clemens MG; Zhang JX
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1567-74. PubMed ID: 16928218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.
    Fernando B; Marley R; Holt S; Anand R; Harry D; Sanderson P; Smith R; Hamilton G; Moore K
    Hepatology; 1998 Sep; 28(3):689-94. PubMed ID: 9731560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
    Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
    World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.
    Schwabl P; Seeland BA; Riedl F; Schubert TL; Königshofer P; Brusilovskaya K; Petrenko O; Hofer B; Schiefer AI; Trauner M; Peck-Radosavljevic M; Reiberger T
    Adv Med Sci; 2022 Mar; 67(1):154-162. PubMed ID: 35272246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of portal pressure in the severity of bleeding in portal hypertensive rats.
    Castañeda B; Debernardi-Venon W; Bandi JC; Andreu V; Pérez-del-Pulgar S; Moitinho E; Pizcueta P; Bosch J
    Hepatology; 2000 Mar; 31(3):581-6. PubMed ID: 10706546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
    García-Pagán JC; Fernández M; Bernadich C; Pizcueta P; Piqué JM; Bosch J; Rodés J
    Am J Physiol; 1994 Dec; 267(6 Pt 1):G984-90. PubMed ID: 7810666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric mucosal resistance to acute injury in experimental portal hypertension.
    Calatayud S; Ramírez MC; Sanz MJ; Moreno L; Hernández C; Bosch J; Piqué JM; Esplugues JV
    Br J Pharmacol; 2001 Jan; 132(1):309-17. PubMed ID: 11156591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of cyclooxygenase 2 and prostaglandin I2 in the development of portal hypertensive gastropathy].
    Wu CX; Shi YJ; Liu CA; Gong JP; Li SW
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):536-8. PubMed ID: 14552713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant role of heme oxygenase-1 in prehepatic portal hypertensive rats.
    Gonzales S; Perez MJ; Perazzo JC; Tomaro ML
    World J Gastroenterol; 2006 Jul; 12(26):4149-55. PubMed ID: 16830363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are humoral factors involved in the colonic mucosal lesion in portal hypertensive rats?
    Yin ZH; Huang RL; Lu HY; Liu XY
    Acta Gastroenterol Belg; 2007; 70(3):271-6. PubMed ID: 18074736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury.
    Forgiarini LF; Forgiarini LA; da Rosa DP; Silva MB; Mariano R; Paludo Ade O; Andrade CF
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):894-9. PubMed ID: 25156898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.